Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonists in T1DM Patients

(1) Background: Glucagon-like peptide 1 receptor agonists (GLP-1 RA) are a class of therapeutic agents that mimic the endogenous incretin hormone GLP-1. While this class of agents is not approved for Type 1 Diabetes (T1DM) due to concern of increased diabetic ketoacidosis (DKA) risk, long-acting GLP...

Full description

Bibliographic Details

Published in:	Endocrines
Main Authors:	Deene Mohandas, Jamie Calma, Catherine Gao, Marina Basina
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	GLP-1 type 1 diabetes adjunct therapy to insulin semaglutide
Online Access:	https://www.mdpi.com/2673-396X/4/1/8